Moreover, CD103+ TRM cell-derived granzyme B and IFN-γ in humans control tumor formation and metastasis through fibronectin secretion, facilitate the priming of newly generated tumor-specific T cells, and boost immune cell recruitment in the tumor [285]. The gene discussed is GZMB; the disease is neoplasm.